tiprankstipranks
Recursion Pharmaceuticals (RXRX)
NASDAQ:RXRX
US Market
Want to see RXRX full AI Analyst Report?

Recursion Pharmaceuticals (RXRX) Blogger Opinions & Sentiment

4,445 Followers

Blogger Sentiment

Bullish: 83.33%
Sector Average
Bullish
RXRX Blogger sentiment is based on 6 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
50% MotleyFool
33% SeekingAlpha
17% GuruFocus
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Recursion: No Longer An AI 'Pet Science Project,' But Still A 'Sell'
SeekingAlpha
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Recursion Pharmaceuticals: Upgrading To Buy - My Most Surprising Call Of 2025
SeekingAlpha
Recursion (RXRX) Reveals Promising Phase 1b/2 Results for FAP Treatment
GuruFocus
4 Healthcare Stocks to Buy Now
MotleyFool
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any
Blogger Name
Blogger Rank
Blog
Date
Blogger Sentiment​
Article
Follow

FAQ

What do Seeking Alpha bloggers think of RXRX?
Seeking Alpha’s Clover Biotech Research has a Bearish Sentiment.
    What do Motley Fool contributors think of RXRX?
    Currently there's no blogger sentiment for RXRX.
    What Is RXRX’s Blogger Sentiment?
    RXRX’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for RXRX?
      The most recent blogger prediction for RXRX was made by Clover Biotech Research, who was Bearish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          PRRUFImmutep Ltd
          PRNAFAlterity Therapeutics
          PBIGFParadigm Biopharmaceuticals
          NURPFNeuren Pharmaceuticals Limited
          MEOBFMesoblast Limited